Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Marc Laurelle"'
Autor:
Matcheri S. Keshavan, L. Fredrik Jarskog, Cameron S. Carter, Margaret A. Peykamian, Michael F. Green, Larry J. Seidman, Alan Breier, Martin T. Lowy, John G. Csernansky, Jeffrey A. Lieberman, Joshua T. Kantrowitz, Donald C. Goff, Stephen R. Marder, Richard S.E. Keefe, M. Patricia Ball, Robert P. McMahon, Joseph P. Horrigan, Robert W. Buchanan, Marc Laurelle, Paul Maruff, Richard Grove
Publikováno v:
Schizophrenia Research. 164:136-142
This Phase II exploratory study assessed GSK239512, a brain penetrant histamine H₃ receptor antagonist, versus placebo on cognitive impairment in 50 stable outpatients with schizophrenia. Subjects were randomized to placebo or GSK239512 for 7 weeks
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cf45603c5fc671ab113c8cd5ece30aa5
https://doi.org/10.1016/j.schres.2015.01.041
https://doi.org/10.1016/j.schres.2015.01.041
Autor:
L Fredrik, Jarskog, Martin T, Lowy, Richard A, Grove, Richard S E, Keefe, Joseph P, Horrigan, M Patricia, Ball, Alan, Breier, Robert W, Buchanan, Cameron S, Carter, John G, Csernansky, Donald C, Goff, Michael F, Green, Joshua T, Kantrowitz, Matcheri S, Keshavan, Marc, Laurelle, Jeffrey A, Lieberman, Stephen R, Marder, Paul, Maruff, Robert P, McMahon, Larry J, Seidman, Margaret A, Peykamian
Publikováno v:
Schizophrenia research. 164(1-3)
This Phase II exploratory study assessed GSK239512, a brain penetrant histamine H₃ receptor antagonist, versus placebo on cognitive impairment in 50 stable outpatients with schizophrenia. Subjects were randomized to placebo or GSK239512 for 7 weeks
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::63aee1f616ea869813d07a6ffc2518a6
https://pubmed.ncbi.nlm.nih.gov/25728831
https://pubmed.ncbi.nlm.nih.gov/25728831
Autor:
Robert T. Malison, Mohammed S. Al-Tikriti, Shaoyin Wang, Eileen O. Smith, Richard A. Milius, John L. Neumeyer, Robert B. Innis, Paul B. Hoffer, Dennis S. Charney, Michael G. Stabin, Ronald M. Baldwin, Sami S. Zoghbi, Marc Laurelle, Yolanda Zea-Ponce, Elzbieta H. Sybirska
Publikováno v:
Nuclear Medicine and Biology. 20:597-606
The in vivo properties of a new radioiodinated probe of the dopamine and serotonin transporter, [123I]methyl 3β-(4-iodophenyl)tropane-2β-carboxylate ([123I]β-CIT) were evaluated in baboons and vervet monkeys. The labeled product was prepared in 65
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::560d451751c097b79f1b4bb43446936c
https://doi.org/10.1016/0969-8051(93)90028-s
https://doi.org/10.1016/0969-8051(93)90028-s